Skip to Main Content

Measurement in Neuropsychiatric Biomarkers

October 17, 2022
  • 00:00It just feels good
  • 00:02to see all these people here in this room,
  • 00:04and it feels even better to have the
  • 00:07opportunity to introduce Doctor Adam Naples.
  • 00:10So I have known Adam and worked
  • 00:12closely with Adam for a long time.
  • 00:14Adam is a is a long-term denizen
  • 00:17of the Child Study Center.
  • 00:19He through a kind of interesting
  • 00:21and circuitous path.
  • 00:22Adam started out as a musician,
  • 00:25was admitted to the Berkeley School of
  • 00:26Music and was there and got exposed to music
  • 00:29therapy and found the psychology part.
  • 00:30Of the music therapy,
  • 00:32maybe more interesting than the music.
  • 00:34So he transferred to Cornell,
  • 00:35got his degree in psychology,
  • 00:37came to Yale,
  • 00:38got his PhD in cognitive science,
  • 00:40and has been here in various
  • 00:41ways until he was promoted to
  • 00:44assistant professor this past July.
  • 00:46As one might infer from making the pivot
  • 00:50from guitar to statistical genetics,
  • 00:53Adam is a person who is good
  • 00:56at a lot of different things.
  • 00:58Adam is very good at statistics
  • 01:00he's knowledge about. Genetics.
  • 01:01He's knowledge about neuroscience,
  • 01:03cognitive science.
  • 01:04And I like to say if if anything
  • 01:07operates using electricity,
  • 01:09Adam understands it better than you and
  • 01:12can make it work better than anybody else.
  • 01:15He is wildly creative in the work
  • 01:18that you'll hear about today.
  • 01:20He has built experiments,
  • 01:21he's built machines,
  • 01:23he's built labs,
  • 01:24and he's equivalently creative
  • 01:26in terms of his ideas.
  • 01:27And so you're going to hear
  • 01:28very creative ideas as well.
  • 01:31Adam is
  • 01:32a he's a a very.
  • 01:35Prolific collaborator.
  • 01:36He is known in in our field internationally
  • 01:39for his expertise specifically in
  • 01:41things like eye tracking and EEG which
  • 01:44both these electricity and he Umm,
  • 01:46yeah, I'm going to be quiet.
  • 01:49I want to just highlight one thing it is,
  • 01:51it is such a it's a such a great
  • 01:54achievement for Adam to be here as
  • 01:56an assistant professor and it's also
  • 01:58such a great achievement for Yale
  • 02:00because as we recognize one of the
  • 02:02challenges of the academic system
  • 02:03is being as collaborative as Adam.
  • 02:05Can in weird ways be attention
  • 02:08with the promotional process.
  • 02:09And so Adam being here is
  • 02:11an achievement for Adam,
  • 02:12and it's also an achievement for Yale.
  • 02:14And really embracing Team Science is
  • 02:15what we we know that we need to do.
  • 02:18And with that, I give you Adam,
  • 02:20who is my closest colleague and my very,
  • 02:22very dear friend.
  • 02:40Thank you, Jamie, that.
  • 02:43Is a lots to follow. It's it.
  • 02:47It is. As Jamie mentioned,
  • 02:50I've been here for years and
  • 02:53it's it's pretty amazing to be
  • 02:55giving this talk right now.
  • 02:57I've seen a lot of very, I've seen
  • 03:01a lot of amazing talks in this room.
  • 03:03For maybe the past like 18 years or so,
  • 03:07and I'm just going to disable some of
  • 03:10these distracting things over here.
  • 03:14So as you mentioned,
  • 03:16I'm a cognitive psychologist by training.
  • 03:18My research is really focused
  • 03:20on using measurement and methods
  • 03:22from cognitive psychology to
  • 03:23understand individual differences.
  • 03:25And today I'm going to talk
  • 03:26to you about a lot of our work
  • 03:28studying biomarkers and autism.
  • 03:29And so if anything's unclear,
  • 03:31ask me a question and I'll try
  • 03:33to make it more clear. And then.
  • 03:35All right, you can see my mouse.
  • 03:36Great.
  • 03:39So just a quick overview, just I'm
  • 03:41going to tell you what biomarkers are,
  • 03:42why they're important because we hear
  • 03:44this word a lot and I use it a lot,
  • 03:46but it's always good to be reminded.
  • 03:50I'm going to talk to you about large
  • 03:52scale biomarker research and autism that
  • 03:54have done a lot and a lot of this work.
  • 03:56All the work I need to
  • 03:57talk to you about today.
  • 03:58I've done with Jamie as a we've called
  • 04:01collaborated very closely for years.
  • 04:03Then I'm going to talk about some new
  • 04:05experiments that we've designed to be
  • 04:07more inclusive for traditionally very
  • 04:09underserved group of kids with autism.
  • 04:11And then finally I'm going to end
  • 04:13with some novel biomarkers that we're
  • 04:15exploring to study social cognition,
  • 04:16but so, so what's a biomarker?
  • 04:19It's a defined.
  • 04:20Characteristic that's measured
  • 04:21as an indicator of a process,
  • 04:23a pathogenic process.
  • 04:26You can look at this definition for a
  • 04:28while and think of all kinds of things,
  • 04:29but biomarkers are things like heart rate,
  • 04:31blood glucose, blood pressure,
  • 04:34their routine measurements,
  • 04:35they're reliable measurements,
  • 04:37and their objective measurements.
  • 04:39So when you go to Quest Diagnostics
  • 04:40and they take their blood,
  • 04:41they take your blood or someone else's blood,
  • 04:43and you get back to that e-mail
  • 04:45with hundreds of numbers, and all of
  • 04:46those things are biomarkers, right?
  • 04:48And some of them are better or worse for.
  • 04:52Different kinds of decisions you might make.
  • 04:54And that's that's really
  • 04:55why we need biomarkers,
  • 04:56because we need to make decisions
  • 04:58about all kinds of things.
  • 05:00We need to make decisions about
  • 05:01who gets an early intervention.
  • 05:04And these are psychiatric
  • 05:05biomarkers I'm talking about here.
  • 05:06But it's not just for psychiatric biomarkers.
  • 05:10We need biomarkers for
  • 05:12more accurate diagnosis.
  • 05:13We need them for treatment selection.
  • 05:15We need them for individualized treatments,
  • 05:17and we need them so we can understand
  • 05:20how treatments are going to
  • 05:21evaluate how well they're going.
  • 05:23So now these are some of these decisions.
  • 05:27That's sort of an abstract way of saying it.
  • 05:29But we might think,
  • 05:30like if you have a kid who's three years
  • 05:31old and they're learning how to read,
  • 05:33you might think,
  • 05:33do I want to put that kid in an early
  • 05:36reading intervention right now?
  • 05:37Right. That's an expensive process.
  • 05:38That's there's limited accessibility to them.
  • 05:41And is that going to help your
  • 05:43kid become a better reader?
  • 05:44If you're worried your kids at risk, maybe.
  • 05:48Or you might wonder, like,
  • 05:49well, you know, somebody said,
  • 05:50my kids not sitting still enough,
  • 05:51should I give that kid?
  • 05:53A stimulant medication for that,
  • 05:55and that's a decision that
  • 05:57many parents struggle with,
  • 05:59many people struggle with,
  • 06:00and it would be really great if we had good,
  • 06:02solid, objective measurements
  • 06:03to help us make those decisions.
  • 06:06They can even be things like,
  • 06:07should I eat cake?
  • 06:08Right, for people with diabetes,
  • 06:10there's Thanksgiving comes along,
  • 06:12they're measuring their blood glucose level.
  • 06:13And then the third cake comes out
  • 06:15and they think, well,
  • 06:15should I have this third cake?
  • 06:17Let me check where I'm at,
  • 06:19and I'm going to give you an example
  • 06:21of a very concrete biomarker,
  • 06:22and I'm going to come back to
  • 06:24it repeatedly here.
  • 06:25It's heart rate.
  • 06:25And I like heart rate because I
  • 06:28think probably half the people in
  • 06:30this room are measuring their heart
  • 06:32rate right now on their watch.
  • 06:33And it's a. It's it's ubiquitous.
  • 06:37It's so ubiquitous.
  • 06:37You don't think about it as a
  • 06:39biomarker anymore.
  • 06:39We just think of it like it's a
  • 06:41measurement and it's such a good and
  • 06:43reliable measurement that people use
  • 06:44it for all kinds of things that people, the,
  • 06:46you know, initial studies of heart rate,
  • 06:48which are in the prehistory at this point,
  • 06:51probably never conceived of.
  • 06:55Things about heart rate.
  • 06:56Well, it's routine.
  • 06:57I measure my heart rate every second.
  • 07:00I think on my wrist.
  • 07:02It's reliable.
  • 07:03My heart rate is under
  • 07:05the same circumstances,
  • 07:06the same as it is the day before,
  • 07:08and it's subjective.
  • 07:09So it's signing a light through my wrist,
  • 07:11it's measuring the blood reflectance,
  • 07:13doing some math to those signals,
  • 07:14and then coming back with a number.
  • 07:17That's not to say that
  • 07:19that process is perfect,
  • 07:21but it always gives you the
  • 07:22same output for the same input,
  • 07:24and that way it's objective
  • 07:26and very reliable.
  • 07:27And so now that we have this
  • 07:29biomarker that's on my wrist,
  • 07:30we can use it for all kinds of fun things.
  • 07:33So well,
  • 07:34we can use it for early intervention.
  • 07:36And you can see there that little
  • 07:38blue line by resting heart rate
  • 07:40goes from 55 to 80 in a day,
  • 07:42which is a little bit unusual.
  • 07:43And that's when I got my
  • 07:45second COVID booster right.
  • 07:46The heart rate predicted the
  • 07:48onset of a pretty prolonged and
  • 07:51exciting experience dealing with
  • 07:53that heart rate used in many,
  • 07:54many diagnostic tests if you've been to
  • 07:56a doctor and they've checked your heart rate.
  • 07:58That's it.
  • 08:00They follow it.
  • 08:02I'm running out of time,
  • 08:04so it's also used for treatment selection
  • 08:06so I can go for a run on my watch and it
  • 08:08suggests you know what you should do today?
  • 08:10Based on my heart rate over
  • 08:11the past couple of months,
  • 08:12you should go for a 27 minute
  • 08:14run at 11-5 minute mile,
  • 08:16which is not very impressive.
  • 08:18No,
  • 08:18I don't have to follow this advice,
  • 08:19but it's at least it's giving
  • 08:21me an individualized treatment,
  • 08:23right?
  • 08:25And then it evaluates how well I did,
  • 08:28and that treatment too.
  • 08:29So if I fail to follow that,
  • 08:30it uses the language of an NIH grant
  • 08:32reviewer and it tells me that my my
  • 08:35training status was unproductive.
  • 08:36So this is, I think, kind of a a
  • 08:39motivating example of once you get really,
  • 08:41really good, inexpensive,
  • 08:42reliable and effective measurements,
  • 08:45then they might not be used for whatever
  • 08:47you thought they were going to be used for.
  • 08:50But now they're tools,
  • 08:51they're screwdrivers,
  • 08:52they're hammers.
  • 08:52And so people can use them for
  • 08:54whatever their imaginations.
  • 08:55Guide them to their hypothesis generating,
  • 08:59but we're not talking about heart rate,
  • 09:01we're talking about autism.
  • 09:02So I'm going to get to that quickly.
  • 09:05All right,
  • 09:05so talk about autism.
  • 09:09I think the first time I saw this slide
  • 09:12was in this room maybe 20 years ago.
  • 09:15Was diagnosed early in life.
  • 09:16It's heterogeneous syndrome.
  • 09:18It's described as defined by
  • 09:21persistent challenges in social
  • 09:23communication and social interaction,
  • 09:25restricted repetitive patterns of behavior,
  • 09:27sensory sensitivities.
  • 09:28What's common among all diagnosis of
  • 09:30autism is that they're associated with
  • 09:33challenges and reciprocal social behavior.
  • 09:36But the mechanisms for autism are unknown,
  • 09:38and our current current tools
  • 09:40for assessment are subjective.
  • 09:41Report. They're subjective report
  • 09:43from a person who's.
  • 09:45You know,
  • 09:45reporting on themselves from a parent,
  • 09:47reporting on their child or
  • 09:48caregiver on their child,
  • 09:49someone interacting with the person.
  • 09:51And it's not to say these
  • 09:52aren't very good measures,
  • 09:54but they're still not necessarily
  • 09:55the same thing as the same exact
  • 09:58output for the same input that we get
  • 10:00from shining a light for your wrist.
  • 10:03Umm. And so.
  • 10:06With that heterogeneity,
  • 10:08with that unknown mechanisms,
  • 10:09there's there's many theories of what
  • 10:12the underlying causal deficits are in autism.
  • 10:15And I'm going to really briefly
  • 10:16go over a couple of them.
  • 10:17And the point here is to give
  • 10:19you an idea of the breadth and
  • 10:20how these theories hit different
  • 10:22levels of abstraction rather than
  • 10:23they go into detail about anyone,
  • 10:25because that would be hours and hours,
  • 10:27that would be a dissertation defense,
  • 10:29so.
  • 10:31I could talk about social motivation,
  • 10:34predictive coding.
  • 10:34These are different levels of analysis,
  • 10:37just regulated arousal.
  • 10:39And the imbalance or imbalance of
  • 10:42excitation and inhibition in the brain.
  • 10:46The social motivation which
  • 10:47has a strong history here.
  • 10:49Both Jamie and Cara published on it
  • 10:51together here and at other universities.
  • 10:54Briefly,
  • 10:54and I'm terrified to talk
  • 10:56about it in front of you guys,
  • 10:58we can describe this as reduced motivation
  • 11:01to interact and attend to other people.
  • 11:04And this starts early in development.
  • 11:05And so the cascading consequences of this
  • 11:07are you pay less attention to other people,
  • 11:10you interact with people less,
  • 11:12and so you learn less about other people.
  • 11:14And it's harder to develop sort of
  • 11:16social mastery and expertise about
  • 11:18other people if that's not the
  • 11:20world that you're interacting with.
  • 11:23So this is really, really.
  • 11:24Primarily inspired by the
  • 11:26social symptoms of autism.
  • 11:30So. Secondly, I'm going to
  • 11:33talk about what's called the
  • 11:34predictive coding theory of autism.
  • 11:36Predictive coding is a if you Google this,
  • 11:37you get a lot of things that
  • 11:39don't have autism to do with it.
  • 11:40But the idea is that in the brain,
  • 11:42the brain has worked.
  • 11:43Brain works by continuously generating
  • 11:45predictions about the environment,
  • 11:46and these are implicit, not explicit.
  • 11:48Like I'm going to make a prediction
  • 11:50about what's going to happen today.
  • 11:51These are things like low level
  • 11:53sensory input all of the way up,
  • 11:56and most of these predictions are wrong.
  • 11:58And so we learn about the world.
  • 12:01Based on how we deal with the amount
  • 12:04of wrongness of these predictions,
  • 12:06and there's some evidence that
  • 12:08people autism learn from those
  • 12:09prediction errors differently.
  • 12:11And similarly to social motivation,
  • 12:14this is happening early in
  • 12:15development and it cascades.
  • 12:16So starting from, you know,
  • 12:17very young age.
  • 12:20They're learning about the
  • 12:21environment differently,
  • 12:22but in this case it's not specific
  • 12:23to social things.
  • 12:24It's more kind of kind of about everything.
  • 12:27And the a lot of the inspiration for
  • 12:29these theories comes from the sort of
  • 12:32sensory symptoms that people often
  • 12:33report increased sensitivity sounds
  • 12:35or people will also report that some
  • 12:38kids have decreased sensitivity to.
  • 12:422 sounds to.
  • 12:45All right. I just got a high heart rate
  • 12:48alert from my walk and so it's a I'm going
  • 12:51to take that off before it calls 911.
  • 12:57So that that's predictive coding,
  • 13:00not necessarily social,
  • 13:01still about learning and learning
  • 13:03differently about the world.
  • 13:04And you'll see that most of the time we
  • 13:05were talking about anything developmental,
  • 13:06it's about learning about the world.
  • 13:09Alright. Now dysregulated arousal,
  • 13:10I've put these references here at the bottom
  • 13:13just to show that in 1961 they're doing
  • 13:15the same experiments that we're doing now.
  • 13:17So we think about arousal,
  • 13:18we're talking about these overall
  • 13:19states of brain and body.
  • 13:21We think and describing this sort of the way
  • 13:25people describe or things like sweating,
  • 13:27high heart rates, you know,
  • 13:29behavioral activation,
  • 13:30you can't sit still.
  • 13:31Alternatively,
  • 13:31insensitivity, you know,
  • 13:32you're not sensitive to sounds
  • 13:35or external stimuli or sleep,
  • 13:37you're.
  • 13:40It just less sensitive.
  • 13:42So at the extreme ends we have sleep
  • 13:45for arousals like the low end.
  • 13:47And this there is evidence that
  • 13:49these are always are typical in ASD,
  • 13:51primarily from physiological research.
  • 13:53So disregulated Physiology and heart rate,
  • 13:56sleep, sweating, pupil diameter,
  • 14:00sound sensitivity, sound insensitivity,
  • 14:02pain sensitive pain insensitivity.
  • 14:07And then lastly,
  • 14:08there's this theory of that autism.
  • 14:10These symptoms emerge from an imbalance
  • 14:13of excitation and inhibition in the brain.
  • 14:16And the attractive thing about this
  • 14:19theory about many of these is that.
  • 14:22A dysregulation of excitation in the whole
  • 14:25brain is going to impact everything.
  • 14:28And autism is tremendously heterogeneous and
  • 14:31their symptoms that emerge that are sensory,
  • 14:33their cognition, their motor,
  • 14:35which I haven't talked about.
  • 14:37There's also an increased
  • 14:39occurrence of seizures and autism.
  • 14:41And so. That's the we call that
  • 14:45the EI balance just for.
  • 14:47So lots and lots of theories.
  • 14:48They're hitting at different
  • 14:49levels of abstraction.
  • 14:50But, but I'm a cognitive psychologist.
  • 14:52And so when I was an undergrad,
  • 14:54somebody gave me this book
  • 14:54and they said to read it,
  • 14:55and I couldn't get too far
  • 14:57and it was too hard for me.
  • 14:59But all those theories are not
  • 15:01really mutually exclusive.
  • 15:03And this book came out and it's about vision.
  • 15:07It's not about autism.
  • 15:07But it gave sort of a rubric for
  • 15:09thinking about lots and lots of theories.
  • 15:11And if the idea is that, look,
  • 15:12we can break down any information
  • 15:14processing system and into how
  • 15:16it's approaching its problems,
  • 15:17there's a computational level which is just.
  • 15:19What's the problem?
  • 15:20It's trying to solve?
  • 15:21There's the algorithmic level,
  • 15:22which is the the individual steps that
  • 15:25you have to take to solve this problem.
  • 15:26And anyone who is in a cognitive
  • 15:28psychology class in the late 90s,
  • 15:30there's lots and lots of
  • 15:31boxes and arrows for lots,
  • 15:32you know these these super complicated
  • 15:35models that did chess and cooking and,
  • 15:37you know flight path organization and
  • 15:39said this is how the brain works.
  • 15:42And then there's the implementation
  • 15:43level and that's what what's actually
  • 15:45doing the computing in a computer,
  • 15:47it's silicon chips and a brain, it's.
  • 15:49Green.
  • 15:53So I feel like I think about these things,
  • 15:55and I said, can we align them in kind
  • 15:57of a meta theory because they're
  • 15:59not necessarily mutually exclusive?
  • 16:00We can think about social motivation as sort
  • 16:02of addressing this computational problem,
  • 16:04right? We want to make friends.
  • 16:05We want to learn about other people.
  • 16:07What are the steps we go through
  • 16:09to do that predictive coding is?
  • 16:13You know, really fits in sort of
  • 16:15this algorithmic level and it's
  • 16:17aligned with these sort of low level
  • 16:19information processing demands where
  • 16:21we deploy our eye movements and seems
  • 16:23how we learn from different kinds of
  • 16:26statistical regularities in the world.
  • 16:28And then from the implementation level,
  • 16:30we have excitation and EI and
  • 16:32we have just regulated arousal.
  • 16:34Cells firing you know too much or body
  • 16:38state and brain state up or down.
  • 16:41Right.
  • 16:42So these theories generate a lot
  • 16:45of hypotheses,
  • 16:46but what we don't know and so I
  • 16:48was briefly went through this but
  • 16:50you know hundreds of papers on
  • 16:52on many of these topics.
  • 16:53There's a lot of research in autism
  • 16:55as I'm sure you are all aware,
  • 16:56but we we need to kind of know which
  • 16:58ones work before we put it on our wrist.
  • 17:01And even then it's not perfect.
  • 17:02It's almost called the police.
  • 17:04So I'm going to talk about biomarker,
  • 17:05not the police,
  • 17:06just just 911 in general.
  • 17:07And ASD, I'm going to talk to you
  • 17:09about the tools that we use here.
  • 17:11All right.
  • 17:12So EG what's EG EEG is let
  • 17:15me know if I stray too far.
  • 17:17It's the sum of the ongoing cortical
  • 17:20activity recorded of the scalp
  • 17:22reflects the excitatory and inhibitory
  • 17:24postsynaptic activity in the cortex.
  • 17:26Way we measure it is we take
  • 17:28this soft spongy cap with little
  • 17:30electrodes in the wires.
  • 17:31You put it on your head and we use
  • 17:33those little electrodes with a very
  • 17:35expensive amplifier to amplify the
  • 17:36very faint electrical signals generated
  • 17:38by your brain into a recording.
  • 17:40And the recording looks like this.
  • 17:42So each one of these wiggly
  • 17:44lines is the voltage.
  • 17:45Measure your scalp, and this is amplitude.
  • 17:48So how loud, how big the voltage is.
  • 17:50And this is time,
  • 17:51and this is in milliseconds.
  • 17:52This is really, really,
  • 17:53really, really, really fast.
  • 17:54A lot of lines means we're
  • 17:57using lots of electrodes.
  • 17:59And we can learn a lot of things from
  • 18:00this ongoing EG even when people are just,
  • 18:02when they're not doing anything.
  • 18:04One way is we can look at the relative
  • 18:07contribution of the different frequencies.
  • 18:09So the fast wiggles and the slow wiggles.
  • 18:12And what's really interesting is
  • 18:13that the excitatory and inhibitory
  • 18:15neurotransmitters in the brain
  • 18:17have different time constants,
  • 18:18which means that the really lines
  • 18:20wiggle at different speeds for
  • 18:22excitation and they do for inhibition.
  • 18:24So, and I apologize,
  • 18:25I think the language of wiggly lines.
  • 18:27So there's people here who are like serious.
  • 18:29EG computational researchers
  • 18:30and they're like,
  • 18:32you know,
  • 18:33throwing their coffee
  • 18:33on the floor angrily and
  • 18:35leading. But this is still we need to agree,
  • 18:37this is still just a lot of wiggly lines.
  • 18:39Lots of them. So.
  • 18:42Sitting and doing nothing.
  • 18:43It's like a great experiment because we
  • 18:46can use it to measure the I balance,
  • 18:47and this is what's called
  • 18:49the power spectral density.
  • 18:50So what it's measuring on the left
  • 18:53are the volume of the amplitude.
  • 18:56I'm using my hand again of the slow wiggles,
  • 18:59and over here the fast wiggles and
  • 19:01this relative activity across the
  • 19:04frequencies indexes this balance, right?
  • 19:06Like how much excitation,
  • 19:07how much inhibition you have.
  • 19:09Shallower slopes, yes, shallower.
  • 19:12Groups are more excitation,
  • 19:14steeper slopes are more
  • 19:16inhibition and this also changes.
  • 19:17So this is a pretty reliable effect
  • 19:19if you give people different kinds
  • 19:22of pharmacological interventions.
  • 19:23So if you give people Ambien,
  • 19:25well actually goes the other way,
  • 19:27so it gets much steeper.
  • 19:28So if people are giving Ambien,
  • 19:30given benzodiazepine,
  • 19:30you see these inhibitions really,
  • 19:32really ramp up. Also this happens in sleep.
  • 19:35So that's one way.
  • 19:36We can look at the EEG 2nd way and this is
  • 19:41again the computational neuroscientists.
  • 19:43You think this is too basic our
  • 19:47event related potentials so.
  • 19:48This is where we average the EEG activity
  • 19:50around repeated presentations of an event.
  • 19:52Like we show you pictures of face,
  • 19:53we show you pictures of a house,
  • 19:55and then we average the activity.
  • 19:57And so these little chunks of
  • 20:00those activity of these wiggles.
  • 20:02And what that does is it gets rid of
  • 20:03the wiggles that don't have anything
  • 20:05to do with what you're interested in.
  • 20:06And it accentuates,
  • 20:07it amplifies the wiggles that you
  • 20:08do care about and you get what's
  • 20:10called an event related potential,
  • 20:12which has relatively few wiggles.
  • 20:14But those wiggles end up having
  • 20:16names and they're important for
  • 20:17learning about brain activity.
  • 20:18And down here time this is in milliseconds.
  • 20:22So this is really really fast.
  • 20:24So I want to highlight this is like
  • 20:26that's a feature about EEG and ERP's
  • 20:29that is not captured in many other. Umm.
  • 20:33Somebody put something in the chat.
  • 20:34I'm going to try not to be distracted by it.
  • 20:38And we're going to talk to you about
  • 20:40now probably the most important ERP
  • 20:42for this talk, which is the N 170.
  • 20:46So the N 170 and it's in this
  • 20:49red circle right here.
  • 20:51When we show people faces compared to almost
  • 20:54any other visual object in the world.
  • 20:57Almost.
  • 20:57You get this much more negative.
  • 21:00Even the negative ones we call peaks much
  • 21:03earlier peak to faces than anything else.
  • 21:06We called the N 170.
  • 21:07This is 170 milliseconds.
  • 21:09This is really fast,
  • 21:11right?
  • 21:11We other kinds of measures that are slower.
  • 21:17Are reflecting some different kind
  • 21:18of thing like if you hit a button
  • 21:19when you see a face,
  • 21:20that's like what you saw the face.
  • 21:21But then decision process has
  • 21:22worked in this is at the level of
  • 21:24like action right now.
  • 21:25This is what is probably,
  • 21:27we think subserving how we interact
  • 21:28with people in the world, right.
  • 21:30When you look around,
  • 21:31every time I see a face,
  • 21:32that part of brain is sort of firing
  • 21:34up and saying up face something bigger
  • 21:36right there and it's it's meaningful.
  • 21:40Umm. So it's a selective to faces.
  • 21:44It's really very early, which I'll
  • 21:46keep saying it's sensitive to context.
  • 21:48So if I tell you that like I'm
  • 21:50going to show you a bunch of faces
  • 21:51of people who are judging you,
  • 21:52judging how you dress.
  • 21:53In fact was a recent study,
  • 21:55you're 170 is different,
  • 21:57it's sensitive to gaze too.
  • 21:59So if gays changes,
  • 21:59when you look at a person's face
  • 22:01and they look away, you get in 170.
  • 22:03So movements of eyes seem to be really,
  • 22:06really important for understanding
  • 22:07this really early brain activity which
  • 22:10is meaningful and social interaction.
  • 22:11Guys are important.
  • 22:13Can they move fast?
  • 22:15So Umm,
  • 22:17now just briefly this is 1 slide
  • 22:19and it's not nearly enough on
  • 22:21EEG findings and ASD that are not
  • 22:23all of them and but are relevant
  • 22:25to this talk which is one.
  • 22:27I guess I'll start with the 4th point,
  • 22:30which is in general patterns of
  • 22:33findings are heterogeneous and
  • 22:34that's the case in in many fields.
  • 22:37But the most consistent among
  • 22:39inconsistent findings is is delayed
  • 22:40in 170 that people with autism it's
  • 22:43less efficient phase processing or less.
  • 22:45Less fluent space processing.
  • 22:47There's also evidence that that
  • 22:49the profile that spectral profile
  • 22:51is atypical in that it's.
  • 22:54It's the shape seems to be different.
  • 22:56Specific features of how it's
  • 22:59different can vary among studies.
  • 23:01All right, so there's EG now eye tracking.
  • 23:04So eye tracking,
  • 23:05and I think this is this is
  • 23:07actually really intimidating to
  • 23:09even eye track we're talking here.
  • 23:11Ever take a video of your eye and use
  • 23:12it to figure out where you're looking?
  • 23:16And you end up with a really long
  • 23:18spreadsheet, just of coordinates
  • 23:19of where someone is looking.
  • 23:20But it's really, really useful
  • 23:22because with that information you can
  • 23:24figure out where someone's looking
  • 23:25at a social scene the faces are not.
  • 23:27You can also look to see how that attention
  • 23:30unfolds over time. And as a bonus,
  • 23:32you can look at pupil diameter,
  • 23:34which is a nice measure of arousal.
  • 23:37Eye tracking ASD again.
  • 23:40In a nutshell. Wow. God, I spoiled it.
  • 23:46General attenuated looking
  • 23:47to social information.
  • 23:49This is replicated across many, many,
  • 23:51many studies with different stimuli.
  • 23:53Again, with any one of these papers,
  • 23:55I guarantee you can find another
  • 23:56paper showing an opposite pattern
  • 23:58or a failure to replicate,
  • 23:59but these are fairly consistent and also
  • 24:02attenuated pupil constriction to light,
  • 24:03and this goes back to the 60s.
  • 24:05The idea is that arousal is too high,
  • 24:07and so when you flash the
  • 24:08light in someone's eyes,
  • 24:09there's more norepinephrine kind
  • 24:10of going through the brain,
  • 24:12and so it just won't constrict a lot.
  • 24:16So briefly. Want to point out that these.
  • 24:22Findings target different levels of
  • 24:24abstraction but they reflect pretty
  • 24:26modest sample sizes and it's in
  • 24:28heterogeneous patterns of finding.
  • 24:29So we got to find out which ones hold up
  • 24:32and then I introduce you to the Autism
  • 24:35Biomarkers Consortium for clinical trials.
  • 24:37Jamie Mcpartland here is the principal
  • 24:39investigator of this and the goal
  • 24:40of this project is to test these
  • 24:42well evidenced biomarkers and A5
  • 24:44slight clinical trial model using
  • 24:46egg and I tracking because they're
  • 24:48inexpensive and practical like my watch.
  • 24:50Targeting social community performance,
  • 24:52but not only that,
  • 24:53so we have some other measures in there and.
  • 24:56The characteristics of the kids are there.
  • 24:59I'm going to talk to you about
  • 25:01some of the results,
  • 25:02primarily in the context of
  • 25:04the theories I talked about.
  • 25:05So social motivation disregulated arousal and
  • 25:08tell you about what the experiments were.
  • 25:10So. I've talked a lot about the inland 70s.
  • 25:12The first thing we had to do was
  • 25:14just show kids a bunch of faces
  • 25:16and just look at their address.
  • 25:1870, but not like few kids.
  • 25:19We, as you saw two hundred 399 kids.
  • 25:23Umm,
  • 25:24there's evidence that's delayed,
  • 25:26but we really want to know and
  • 25:27escale like what the characteristics
  • 25:29of this measurement are.
  • 25:31And we think about this as sort of
  • 25:33measurement for indexing social innovation.
  • 25:34And this is really,
  • 25:35this is the experiment that the kids see.
  • 25:38So just so we can all sort of
  • 25:40have some audience participation.
  • 25:42Then with eye tracking,
  • 25:43we looked at what's called the
  • 25:44composite Ocular Motor Index.
  • 25:46So again evidence that people thought
  • 25:48some look less to social information.
  • 25:50So we showed people different kinds
  • 25:52of dynamic and static scenes and we
  • 25:54just measured how much people look at
  • 25:56faces and then average that across that.
  • 25:58So you can see.
  • 26:00So these.
  • 26:02Overlays here indicate sort of the
  • 26:04regions of interest for our analysis.
  • 26:09Again, social interest.
  • 26:10Then we look at arousal,
  • 26:12pupillary light response.
  • 26:13Very simple experiment.
  • 26:15We have this really intriguing little
  • 26:17circle thing in the middle that sort
  • 26:19of loops around the noise, nice noise.
  • 26:21And then for 66 milliseconds
  • 26:22of white flash on the screen.
  • 26:24All we're doing is we're
  • 26:26measuring how fast your pupil can
  • 26:27starts to constrict after that.
  • 26:29And there it is.
  • 26:31And finally,
  • 26:32we love this experiment because
  • 26:34no one has to do anything.
  • 26:36We just show these little screen
  • 26:38savers and for for two minutes and
  • 26:41we just measure your resting EEG.
  • 26:42So we can look at the slope
  • 26:45of the resting EEG as a marker
  • 26:47as an index of EI balance.
  • 26:49So the bridge results on these.
  • 26:52On these experiments SO1 participants
  • 26:56with ASDF slower and 170 so on the left.
  • 26:59This is our waveform ASE is in green.
  • 27:02TD's in blue.
  • 27:04You can see that the group of kids
  • 27:08with autism is significantly later.
  • 27:10All the results are I'm showing
  • 27:11you will hold up even when we
  • 27:14include age and cognitive ability
  • 27:15as a covariance on the right.
  • 27:17This is a sort of a stacked histogram
  • 27:19of anyone 70 so you can see a SD
  • 27:21on the left and TD on the right.
  • 27:23We see this sort of longer term not
  • 27:26relative a decent chunk of variety
  • 27:28of kids with autism will reach
  • 27:31show this slower and with 70s so.
  • 27:35The Ocular motor index.
  • 27:37There's a very large effect size that
  • 27:39kids with autism look less two faces.
  • 27:42So this is again,
  • 27:43controlling for age and cognitive ability.
  • 27:46And in line with what we know
  • 27:48about social motivation is that
  • 27:49the less you look at people,
  • 27:51the less you learn about people.
  • 27:52And so here's evidence for just
  • 27:54less interest in looking at people.
  • 27:56For the PLR, slower PLR construction.
  • 27:59So this is a latency, I'm sorry,
  • 28:01it's a little delayed here,
  • 28:02the latency of the PLR and autism
  • 28:04and in typical development and we
  • 28:07see that kids with autism have a
  • 28:09slower constriction to pillar and we
  • 28:11think this is an index of increased
  • 28:13sympathetic noradrenergic activity.
  • 28:16And finally, the shallower EEG slope
  • 28:18that we find in kids with autism,
  • 28:21it's a little hard to see,
  • 28:23but that green line is significantly
  • 28:25different than the blue line,
  • 28:28which shows us that we have more excitation
  • 28:30relative to inhibition in this group.
  • 28:36One nice interesting thing we found out.
  • 28:39And we hope to find out was that this
  • 28:41also this the slope and the shape of
  • 28:42the EEG's are tremendously reliable.
  • 28:45So these shapes, this is just one
  • 28:49person's power spectrum plot.
  • 28:51The blue are on one day and
  • 28:52the red are on another day.
  • 28:53And these shapes are idiosyncratic.
  • 28:56You can pick them apart and like put
  • 28:58them together like it's a matching game.
  • 29:00And so that's very just cool to see
  • 29:02but also lets us know that this is a
  • 29:05this is like a functional of reliable
  • 29:08index of functional. Activity.
  • 29:09So it's not like we're measuring.
  • 29:11We're going up to the kids and we're like up.
  • 29:13Their head still has the weird
  • 29:14bump on it two days later,
  • 29:15like when they go to sleep.
  • 29:16This whole, EG power spectrum,
  • 29:17like shifts over. They're asleep, right?
  • 29:19When they wake up, it's different.
  • 29:21But when they're kind of at their daily idol,
  • 29:24everybody has the same sort of
  • 29:26functional pattern of activity.
  • 29:28Alright,
  • 29:29So what did we see there is that there's
  • 29:31evidence for reduced sodium motion by
  • 29:33social motivation from the 170 and OI,
  • 29:36increased arousal,
  • 29:37increased excitation.
  • 29:38The different biomarkers are hitting
  • 29:40different levels of abstraction,
  • 29:42so these aren't really mutually exclusive,
  • 29:45but there's evidence for multiple
  • 29:46mechanisms to work here.
  • 29:49OK. So what are our next steps with that?
  • 29:52Well, right now we're working on
  • 29:53replication and larger sample looking at
  • 29:55long-term stability of these biomarkers.
  • 29:57So we've got kids back over,
  • 29:59you know, past a year at this point.
  • 30:02And a feasibility study in a younger age
  • 30:04group and feasibility is really important
  • 30:06for any kind of measure because you
  • 30:08want to make sure that your biomarker
  • 30:10can work in people who need it, right.
  • 30:13So if you want to do early intervention,
  • 30:14then you want to be able to
  • 30:16want to make sure that these,
  • 30:17you can use these biomarkers
  • 30:19and a kid and a kid who's,
  • 30:20you know, three or two years old.
  • 30:23So in our process of putting
  • 30:26these analysis together,
  • 30:28we really dug into things like data quality,
  • 30:31which I'm sure is riveting and I'm about
  • 30:33to go into it more, but it's important.
  • 30:35And I'm going to talk to you about
  • 30:37data loss and biomarker measurement.
  • 30:39So we had 399 kids, nine,
  • 30:42399 kids came in for three visits.
  • 30:45Each visit was two days each.
  • 30:46That's a lot of people coming in.
  • 30:48It's a tremendous amount of work.
  • 30:50I'm looking at the clinician
  • 30:51right now who's seen probably.
  • 30:53Hundred of those kids nodding at me
  • 30:55saying yes, I did all of that and
  • 30:57it was a tremendous amount of work.
  • 30:59And our failure on the eye tracking
  • 31:01end is that even though we got 399 kids in,
  • 31:05we didn't get usable EEG data on or
  • 31:08eye tracking data on those 399 kids.
  • 31:12So, and it turns out that this,
  • 31:15this data aren't really missing by random,
  • 31:17right?
  • 31:17The kids were the most impaired are the
  • 31:19kids who were missing the most data on.
  • 31:21So we decided that we needed
  • 31:23to quantify this a little bit.
  • 31:25And I'm going to,
  • 31:26I'll skip through most of this.
  • 31:28This is just sort of you know
  • 31:29how you get like how much,
  • 31:31how you add up your data.
  • 31:32But here's the the.
  • 31:34Important thing is this thing
  • 31:36called valid data right?
  • 31:38You need to have enough valid data,
  • 31:40which is usable data.
  • 31:42Data you can analyze to in
  • 31:44order to make a measurement.
  • 31:46And if we compare groups on valid data,
  • 31:50this is you don't have to look at,
  • 31:52just look at this column.
  • 31:54It's the P values for comparing
  • 31:56the groups on amount of valid
  • 31:58data and it's always significant.
  • 31:59And kids with autism always
  • 32:01have less valid data.
  • 32:02And this continues even
  • 32:04when you control for age,
  • 32:07cognitive ability and data collection site,
  • 32:10which is a ton of.
  • 32:11It's like now we're just almost
  • 32:13throwing things in the model to
  • 32:15try to make that P value go away,
  • 32:17but we weren't.
  • 32:17These are being valid measures
  • 32:19to control for,
  • 32:20but it's still a big effect.
  • 32:23But I think you know many of
  • 32:25you would have predicted that.
  • 32:26So this maybe you would have
  • 32:28predicted this too though which is
  • 32:30that in this sea of significant
  • 32:32correlations it shows that the
  • 32:34amount of valid data you have is
  • 32:38reflects clinical severity across
  • 32:40all of the clinical measures we did.
  • 32:43The take home point.
  • 32:43We lose the most data from the kids.
  • 32:45We're the most impaired.
  • 32:48And it's the rule, not the exception,
  • 32:50so it's significantly correlated
  • 32:52with their individual differences.
  • 32:55And then this one is, is even more fun,
  • 32:57which is that we're losing most
  • 32:58data from those kids who are
  • 33:00looking at least at the faces.
  • 33:01So that's the thing that we think is
  • 33:04the most important marker of clinical
  • 33:06characterization and it turns out.
  • 33:08So the kids who are looking the
  • 33:10least at the faces are the ones
  • 33:13we're losing the most data from.
  • 33:14So the question is,
  • 33:15how do you know that they're
  • 33:17looking the least at the faces if,
  • 33:18and that's kind of you take
  • 33:20this out far enough,
  • 33:21you don't your your measurement precision.
  • 33:26Is the worst in the people
  • 33:28you want it to be the best in.
  • 33:31Um, it's like a this is kind of like
  • 33:33an ECG system that stops working
  • 33:34when your heart rate goes up.
  • 33:36Right. It's really, really,
  • 33:37really great when you're kind
  • 33:38of like a sleep or if you're,
  • 33:40you know, really,
  • 33:41really healthy and you're
  • 33:41running a triathlon.
  • 33:42But if you go in for a stress test,
  • 33:45it just starts to fall apart.
  • 33:46You think that's really when we want it,
  • 33:48though.
  • 33:49Alright.
  • 33:50But also I want to I've just talked
  • 33:51a lot about the missing data.
  • 33:53This is not specific to the ABC TV.
  • 33:55When I first started doing
  • 33:56eye tracking research here,
  • 33:57a very senior person came up to me and said,
  • 33:59oh man, you lose so much data.
  • 34:01Nobody ever tells you about it.
  • 34:02And they were just there sort of crestfallen,
  • 34:04like they work so hard and so the
  • 34:06kids are just like looking at
  • 34:07something in the corner of the room.
  • 34:09But we have so much data that
  • 34:11we can really quantify it.
  • 34:12Now usually this is a byline
  • 34:14like kids who looked less than
  • 34:1650% of the screen were excluded
  • 34:18from our analysis and it's.
  • 34:19Maybe three or five kids.
  • 34:20So you can't really quantify
  • 34:22it in the same way,
  • 34:24so.
  • 34:27Umm. This is data loss from
  • 34:31kids in the ACT 6 to 11.
  • 34:33Their IQ's are from 60 to 140
  • 34:36and you know it's. Still really,
  • 34:39really, really good data quality.
  • 34:42But we've thought about this a lot.
  • 34:44And so a few years ago, well,
  • 34:45kind of working on this for more
  • 34:48than a few years, you know,
  • 34:49Jamie and I came up with the idea of like,
  • 34:51how can we include these kids?
  • 34:53Thank you. 60 to 140,
  • 34:56that's kind of not higher IQ's,
  • 34:58but there's a lot of kids
  • 35:00who still don't hit those,
  • 35:01those targets, they're more impaired.
  • 35:03And so how can we make these
  • 35:06experiments like work?
  • 35:07And how can this system operate
  • 35:09for kids who don't have an IQ of
  • 35:11like 120 and are really motivated
  • 35:13by $100 in a Lego set coming in?
  • 35:16And that we don't give Lego sets.
  • 35:18And I want to make that clear
  • 35:19because I'm being recorded.
  • 35:20It was sort of there's an
  • 35:21illustrative moment,
  • 35:22but I do not want to that to
  • 35:23sort of be false advertising.
  • 35:25So.
  • 35:25So I got to think about a group of
  • 35:27kids that's in significant need of study,
  • 35:29kids with autism and intellectual
  • 35:33disability and.
  • 35:34So approximately 30% of kids with autism
  • 35:37have significant intellectual disability.
  • 35:38They're very,
  • 35:39very underrepresented in neuroscience
  • 35:41research and I would argue the
  • 35:43reason why is that it's hard to get.
  • 35:45Usable brain data, and I'm going to
  • 35:47give you some numbers to come into.
  • 35:49It's a real issue.
  • 35:51So I did some pub Med searching.
  • 35:54From 2020 to now,
  • 35:55molecular Autism is a great journal.
  • 35:57Published 214 articles.
  • 35:59Autism, which is another journal,
  • 36:01published 193.
  • 36:03Autism Research published 140.
  • 36:05In that same time span,
  • 36:07if you go through all the papers and
  • 36:10search for kids with IQ of less than
  • 36:1260 who were in a study with an EEG,
  • 36:15all the papers.
  • 36:15You know, this is not just those journals.
  • 36:17This is JCP and you just add up all the kids.
  • 36:20That's 66 kids.
  • 36:22That's 66 papers.
  • 36:23There's not a paper with 66 kids, 66 kids.
  • 36:27There's like that's crazy.
  • 36:30This is this is 3 journals,
  • 36:34548 seven or eight 45147 articles and
  • 36:36those are like the other review articles.
  • 36:38Those are opinions,
  • 36:40but.
  • 36:41It's it's still a tremendous amount
  • 36:43of work to even just put those
  • 36:46articles out there. Only 66 kids.
  • 36:49So, so what's happening?
  • 36:51Well, it's really hard to get usable data.
  • 36:54So people know this,
  • 36:56it's hard and that's why
  • 36:57there's probably only 60s kids.
  • 36:59So for characterization you need,
  • 37:01you know, specialized staff.
  • 37:02And Christine is a BC BA works
  • 37:05with us and a psychologist and
  • 37:07Julie are experts on this in
  • 37:08the world and they're flexible
  • 37:10with complex characterization
  • 37:12situations and behavioral demands.
  • 37:14The experiments need to be able to
  • 37:16accommodate the participants needs.
  • 37:18So a lot of experiments will say like.
  • 37:20It's still and press a button
  • 37:21when you see a dog.
  • 37:22If a kid doesn't have useful language,
  • 37:24doesn't understand what you're saying,
  • 37:25can't read that on the screen,
  • 37:27that it's not going to work.
  • 37:31And then the data are usually messier.
  • 37:33And so just the analysis.
  • 37:34And this is like the, you know,
  • 37:36the people who are in the back room with,
  • 37:38you know, 50 computers.
  • 37:38And like, we need to come up with a
  • 37:40new kind of experimental pipeline in
  • 37:42order to accommodate this data from
  • 37:44these kids because they move so much.
  • 37:46You typically need more people
  • 37:47and your staff. But that's like.
  • 37:50That's manageable.
  • 37:52And another way,
  • 37:54it's really hard for the families,
  • 37:56like for any of you who have
  • 37:58come to New Haven and tried to
  • 38:00park somewhere comfortably.
  • 38:01Now imagine that you're doing that,
  • 38:02and you have a child who's in
  • 38:04an unfamiliar place who has
  • 38:06difficulty difficulty navigating
  • 38:07these unfamiliar situations.
  • 38:08You take you're missing a day of school.
  • 38:11You're trying to find a place for lunch.
  • 38:13Then it's really hard for the kids
  • 38:15because they're going to some,
  • 38:17because then they sit in front of
  • 38:19this experiment that says press
  • 38:20a button if you see a dog and
  • 38:22you know what's going on.
  • 38:23So. When I say usable data,
  • 38:27that's going to be clear.
  • 38:28These are nice wiggly lines up here.
  • 38:29That's what we want to see.
  • 38:31This is what happens when
  • 38:32someone's moving their head.
  • 38:33And that's like, they're just like,
  • 38:35you know,
  • 38:36adjusting their neck and it's unusable.
  • 38:37It's muscle activity.
  • 38:39This is most of.
  • 38:41This is what happens when
  • 38:42you're not you don't know.
  • 38:44You have to sit still and
  • 38:45you're not sitting still,
  • 38:46and then you can't use this for anything.
  • 38:50The task demands of these experiments,
  • 38:52following verbal or written instructions.
  • 38:54Again,
  • 38:54I'm sitting still is like it's not trivial,
  • 38:56but I keep repeating it,
  • 38:57sustaining your attention and
  • 38:59tolerating an unfamiliar set.
  • 39:01And so our approach to all of this was
  • 39:03instead of just saying it's really hard,
  • 39:06you know,
  • 39:06tough it out,
  • 39:06which I think would probably
  • 39:08not be effective,
  • 39:09it was just to try to make it easy.
  • 39:10So we developed what we call
  • 39:13Pelican is the the probabilistic
  • 39:15and active learning infrastructure
  • 39:16for characterization neuro typing.
  • 39:18So it's an experimental system that
  • 39:20reacts to participants movements,
  • 39:21their eye movements, their attention.
  • 39:23It adaptively teaches participants to
  • 39:25attend to the experiment and monitors
  • 39:27the data quality so it can adapt
  • 39:29what they're seeing in real time.
  • 39:30There's no explicit.
  • 39:32Instructions.
  • 39:32And it's personalized reinforcers.
  • 39:35And I'm going to show you just how it works.
  • 39:36So you come in, well, first of all,
  • 39:39someone calls you on the phone, the parent,
  • 39:41the child, the parent on the phone.
  • 39:42And they say, you know,
  • 39:43what movies does your son or daughter like,
  • 39:45right.
  • 39:46And they say, oh, Bob the Builder.
  • 39:48So maybe not anymore.
  • 39:49But let's just say it's like,
  • 39:51really, really like Bob the Builder.
  • 39:52They've all PBS VHS tapes.
  • 39:54So they come in, we sit them down,
  • 39:55we put this cap on their head.
  • 39:56And that red,
  • 39:57that red mist doesn't mean that they're
  • 39:59hot or smells.
  • 40:00It means they're moving, right.
  • 40:01So they're they're moving and it's plan.
  • 40:04Because they start to move too much
  • 40:05or they look away from the screen and
  • 40:07we're measuring this with cameras.
  • 40:09We're measuring this with a chair that
  • 40:10kind of like monitors acceleration.
  • 40:13We're measuring it with head movement.
  • 40:15So you start moving too much,
  • 40:16Bob stops, all right?
  • 40:18So you start moving a little bit less,
  • 40:20Bob starts playing again.
  • 40:21So the idea is that whenever you attend and
  • 40:25sit Stiller than you were before, right?
  • 40:28Because having someone go from moving around,
  • 40:30sitting completely still is a tall order.
  • 40:32You get reinforced by this.
  • 40:34Personalized reinforcer.
  • 40:35Bob the Builder.
  • 40:37So what this works out to be is
  • 40:38we get attention in this word that
  • 40:40I never know how to pronounce.
  • 40:42Quiescence,
  • 40:42stillness without verbal instructions.
  • 40:46Umm.
  • 40:48Always positive reinforcement and
  • 40:50then the personalized reinforcers.
  • 40:52Actually, this is much more effective
  • 40:54than we thought it would be.
  • 40:56So it's a very unfamiliar place.
  • 40:58But you come in and something very,
  • 40:59very familiar to you is happening.
  • 41:01And it turns out that there's no
  • 41:03way you can have one-size-fits-all.
  • 41:05I mean, we have kids who love Moana.
  • 41:07We have kids who love 80s action
  • 41:09sort of sitcom dramas.
  • 41:11These are all real.
  • 41:12You know, these are not participants,
  • 41:14but these are choices of participants.
  • 41:15And then we have the Chicago bus system.
  • 41:18And we'd never know.
  • 41:19We would have never picked
  • 41:21these up on our own.
  • 41:22But it really helps to navigate
  • 41:25the uncertainty of the room.
  • 41:26And then the last thing is
  • 41:28that adaptive trial delivery.
  • 41:29So we're watching how you're watching
  • 41:31the computer because if we're watching it,
  • 41:33we're too slow,
  • 41:34we're too inattentive.
  • 41:36We're monitoring if you're moving around
  • 41:37when a face pops up on the screen,
  • 41:39right, look for showing your face.
  • 41:40So if you are,
  • 41:41we know that we're never going to be
  • 41:43able to measure effect brain activity
  • 41:44effectively from that trial from that,
  • 41:46you know,
  • 41:4750 milliseconds,
  • 41:4820 milliseconds.
  • 41:51But the way European experiments typically
  • 41:53work is we just show you like 100 faces
  • 41:56or 200 faces and figure we're going
  • 41:58to some of those are going to be OK.
  • 42:00So those of you who have been in an ERP
  • 42:02experiment in college to earn 20 or $30,
  • 42:05you probably fell asleep in it because
  • 42:07they're long and they're boring.
  • 42:08But imagine if we knew. That you watched.
  • 42:12You were sitting still and looking when
  • 42:14twenty faces popped up on the screen.
  • 42:15Well, then we'd be done with that right now.
  • 42:17I'll show you some houses.
  • 42:18Now we'll show you something else.
  • 42:19So we can actually make the
  • 42:22experiment shorter for these kids
  • 42:24than what the standard is.
  • 42:26Would they end up being much longer
  • 42:29than they would normally be for,
  • 42:31like a compliant kid,
  • 42:32you know, with a higher IQ?
  • 42:35So this really reduces the burden.
  • 42:38And so I'm going to talk to you about
  • 42:39this is our twelve kids we've seen.
  • 42:41Unfortunately this was funded during
  • 42:42there's a little bit of pandemic happening.
  • 42:45So we weren't in the lab as
  • 42:48much as we'd hoped to be.
  • 42:50But as you can see from these numbers,
  • 42:52this is a fairly impaired group of kids.
  • 42:55These are the averages are 100 for these
  • 42:59numbers and these are not near there.
  • 43:02The experiments we used we adopted 2
  • 43:05from the ACT, so the faces task and
  • 43:08170 faces and the static social scene.
  • 43:10So we're just showing faces,
  • 43:11we're showing scenes.
  • 43:14And then the results, what do we get?
  • 43:16So run it works.
  • 43:17Oh God, I left it up there.
  • 43:19So yes, but it's exciting.
  • 43:20What these are,
  • 43:21are these are little trajectories
  • 43:23through the experiment.
  • 43:24Each one of these,
  • 43:25this is time along the X axis here.
  • 43:27And this is 1 kid on the top and a
  • 43:29different kids trajectory on the
  • 43:31bottom because the experiment adapts.
  • 43:33So everybody sees different things in
  • 43:34different orders at different times
  • 43:36and you want some way to look back
  • 43:37at that and see how things went.
  • 43:39These blue lines right here indicate
  • 43:41when you're moving too much or
  • 43:43you're not looking at the screen,
  • 43:45and the lollipops indicate when
  • 43:47the system was determined you were
  • 43:49sitting still enough that we could
  • 43:51move on with the experiment.
  • 43:53So.
  • 43:55On top kid,
  • 43:56you can see sort of kid on the
  • 43:58represented by the top line.
  • 44:01Definitely had some periods of
  • 44:02time where he's still learning the
  • 44:04contingencies of the experiment,
  • 44:06but towards the end. Figured it out.
  • 44:09And we have a stable presentation
  • 44:12of the stimuli.
  • 44:13This kid at the bottom learned things really,
  • 44:15really, really quickly.
  • 44:16And what's cool is that so these
  • 44:19different colored lollipops are
  • 44:21different kinds of experimental trials.
  • 44:23We're all done with the lime,
  • 44:24felt like the lime ones.
  • 44:26They've seen enough, good enough,
  • 44:27good data so we didn't have to keep
  • 44:29showing that again and we could focus
  • 44:31on just the ERP face and house tasks.
  • 44:35And we can get measurements.
  • 44:37So this is a grand average ERP and it
  • 44:41doesn't look as clean as 1 from 299 kids,
  • 44:44but from 12 kids we're getting sort
  • 44:46of expected negative deflections that
  • 44:48are earlier for faces, for houses.
  • 44:50And then if we compare these kids,
  • 44:53in the end, 170 latency
  • 44:55against age matched age match,
  • 44:57kids with autism and controls from the ACT,
  • 45:00we see this same pattern of extended latency,
  • 45:03which is really, really exciting.
  • 45:04The the, I guess the the
  • 45:06really important part, it's,
  • 45:08it's important that the 170 is later,
  • 45:10but I think it's more important
  • 45:11that we can measure it all at all.
  • 45:13Because now we can know it's later,
  • 45:15but who knows,
  • 45:15like there's all kinds of other things.
  • 45:17If we don't know that we can
  • 45:19now know we have this tool that
  • 45:21is like wildly applicable.
  • 45:23And so in our next steps,
  • 45:25we've just submitted this for an hour one
  • 45:28ready to deploy it in a larger sample,
  • 45:31tighten up some parts that are
  • 45:32still a little rough on the edges,
  • 45:33eye tracking,
  • 45:34calibration and then incorporate in
  • 45:37other biomarker experiments for that.
  • 45:38OK, this is going to be very fast,
  • 45:41but because I'm.
  • 45:43Sorry, slow enemies like a heart rate.
  • 45:46So the heart rate rate changes
  • 45:47in response to me.
  • 45:48When you go up steps it gets faster.
  • 45:52When you go downstairs,
  • 45:53it gets slower so and you can learn a
  • 45:55lot about somebody's cardiac health
  • 45:56by putting them on a treadmill and
  • 45:57then measuring their heart rate.
  • 45:58That's perhaps some of you have
  • 46:00been in those situations.
  • 46:02So I'd argue that anyone 70 is also.
  • 46:06Responsive to changes in the environment.
  • 46:08And we can learn a lot about somebody's
  • 46:09brain from how it changes in response
  • 46:11to different things in the environment,
  • 46:12like such that I guess,
  • 46:15well,
  • 46:15what's what are the stairs for the Inman
  • 46:1870 and I think it's social interactions.
  • 46:21Social behavior is interactive.
  • 46:23We do know that.
  • 46:25You know,
  • 46:25I gave you the list of the laundry list
  • 46:27of all of the of all the challenges
  • 46:29and symptoms of autism before,
  • 46:31one of them wasn't sitting in a room
  • 46:32alone and watching faces on a screen, right?
  • 46:34That's TV.
  • 46:35And a lot of the kids who come
  • 46:36in are really good at it.
  • 46:38A lot of us in this room are
  • 46:39also really good at that.
  • 46:40But in social interactions are
  • 46:42where we have these challenges.
  • 46:44So if social interactions
  • 46:45are the stairs for the 170,
  • 46:47it would be great to throw EEG caps on
  • 46:49all of you in here at a cost like 170,000.
  • 46:52That person.
  • 46:54But it would be great if we could have
  • 46:55like a version of the stress test in our lab,
  • 46:57like a Stairmaster.
  • 46:58What?
  • 46:58A Stairmaster for the end 170.
  • 47:00So how would we do that?
  • 47:02Well,
  • 47:02let's go back to predictive coding.
  • 47:04So again,
  • 47:05evidence that prediction is different in ASD.
  • 47:10But also remember the 170
  • 47:12sensitive to changes in gays.
  • 47:13And if I tell you that this face on
  • 47:15the screen is like your friend or is
  • 47:17judging your clothes, it changes.
  • 47:19So the animal 70s also sensitive
  • 47:22to expectation and and context.
  • 47:24So how do we build this?
  • 47:26And 170 Stairmaster?
  • 47:27We can do that by trying to simulate the
  • 47:30relevant parts of the social interaction.
  • 47:33So how do we do that?
  • 47:34We have these very simple experiments where
  • 47:36we use eye tracking and EEG simultaneously.
  • 47:39Such that when you look at a face,
  • 47:42there's a that's a fun animation.
  • 47:44Right now, that's your eye movement.
  • 47:47When you look at the eyes of the face,
  • 47:49the face looks back at you.
  • 47:51So this is a really,
  • 47:52really subtle visual change.
  • 47:53It's a really,
  • 47:53really meaningful visual change.
  • 47:54So if you're sitting on a bus and you look
  • 47:57at somebody's face and this happens, this is.
  • 48:00Meaningful.
  • 48:01I don't know how.
  • 48:01Depending on the bus context,
  • 48:03it's going to mean who knows
  • 48:04what kind of things is,
  • 48:05but you shouldn't ignore it.
  • 48:08So in our experiments we can control,
  • 48:10control, predictability,
  • 48:11to make eye contact either
  • 48:13predictable or unpredictable.
  • 48:14We're going to show you the
  • 48:16designs of two experiments.
  • 48:17So in the first one we made
  • 48:19eye contact unpredictable.
  • 48:20These experiments are all a little bit.
  • 48:22Quirky because of the way they operate,
  • 48:24but briefly, we showed people an
  • 48:26arrow on a screen followed by a face,
  • 48:29and if the arrow is pointing up or down,
  • 48:31that queued them to look to the
  • 48:32eyes or the mouth of the face.
  • 48:33And then one of two things could happen.
  • 48:35The thing they look at could open.
  • 48:36So they could look at the eyes and
  • 48:38the eyes open and make eye contact,
  • 48:39or they could look at the eyes
  • 48:40and the mouth opens,
  • 48:41or they could look at the mouth in the mouth.
  • 48:42So four things.
  • 48:444 outcomes there.
  • 48:45What's important is you can't
  • 48:46predict what's going to happen.
  • 48:47You might get eye contact, you might not.
  • 48:50It's 50% of the time.
  • 48:52This is our video of it.
  • 48:55So on the right you see gaze and
  • 48:57on the left you see the sort of
  • 48:59washed out video of what the
  • 49:01participant is seeing.
  • 49:04And I apologize for the iPhone quality,
  • 49:06the 2012 iPhone quality, but the.
  • 49:13So that's our first one.
  • 49:13So we're looking at eye
  • 49:15contact to unpredictable.
  • 49:16Second, now we're making it predictable.
  • 49:19So crossair peers.
  • 49:20You look to the eyes of the face.
  • 49:23After you look,
  • 49:23for about 500 milliseconds,
  • 49:24the gaze will shift.
  • 49:25Now it's looking away from you,
  • 49:26it's going to look at you,
  • 49:27it's looking at you,
  • 49:28it's going to look away from you.
  • 49:29Totally predictable.
  • 49:33And.
  • 49:39I look at the mouth. Nothing happens.
  • 49:41Yeah, it's visually really subtle,
  • 49:44but when you get looked at, you feel it.
  • 49:49OK, we did experiment in two samples.
  • 49:53Finally, able adult with autism
  • 49:55and theoretical controls.
  • 49:57And we also measured continuous
  • 49:58measures of symptom severity,
  • 50:00so we have the the cast.
  • 50:03The SSS calibrated severity score.
  • 50:07Back anxiety inventory. The gas flow.
  • 50:09Glasgow Sensory inventory,
  • 50:11sort of a measure of sensory
  • 50:13hydrogen sensitivity.
  • 50:15Here's our results.
  • 50:16So when I I contact is unpredictable.
  • 50:19You actually get a much
  • 50:20bigger and 170 in autism.
  • 50:22No latency differences and across groups.
  • 50:26The difference between mouth
  • 50:28movement and eye contact was
  • 50:30associated with sensory sensitivity,
  • 50:33autism severity and anxiety.
  • 50:36This is an unpredictable situations.
  • 50:39So and this is the N 170 here in Gray,
  • 50:42this darker colors ASD and the caramel STD.
  • 50:47When it's predictable eye contact.
  • 50:49We now see this later and
  • 50:51170 that we see in the ACT,
  • 50:53although the morphology is a bit different,
  • 50:54there's no amplitude differences
  • 50:56between the groups and there's
  • 50:57also no correlation with the
  • 50:59clinical characteristics.
  • 51:00Those are our clinical characteristics
  • 51:01and we're going to jump over those.
  • 51:03But in summary,
  • 51:04so when I contact unpredictable,
  • 51:06we get these bigger responses associated
  • 51:09with anxiety and sensory symptoms,
  • 51:11but when it's predictable,
  • 51:12we don't see any differences.
  • 51:14And we think this means that.
  • 51:16You know real social interactions
  • 51:18are aren't perfectly predictable or
  • 51:20unpredictable but how you integrate
  • 51:21that information is different
  • 51:23in autism and it's happening
  • 51:24at less than 200 milliseconds.
  • 51:27It might not be faced specific
  • 51:29but the way if you think when two
  • 51:31people are interacting if one
  • 51:32of them's jitter like is slower,
  • 51:34think about when you're talking
  • 51:35to someone on zoom is actually
  • 51:37a great example and there are
  • 51:38like 200 milliseconds behind you.
  • 51:40Just most of the time just give up
  • 51:41just like look you put in the chat.
  • 51:43We'll talk later because that temporal.
  • 51:46Asynchrony is just tanks the
  • 51:49social interaction,
  • 51:51so that might be sort of the kind
  • 51:53of things happening in here.
  • 51:55So.
  • 51:57Our next steps were we're exploring
  • 51:59how shifts in Gaze might impact
  • 52:01impact brain response and looking at
  • 52:03emotional faces and brain response.
  • 52:05Basically, different stairmasters,
  • 52:07treadmills, tilt tables for the M70.
  • 52:10In summary,
  • 52:11we've got different theories hitting
  • 52:13different levels of abstraction,
  • 52:15evidence for multiple systems being impacted,
  • 52:19and.
  • 52:20Promising biomarkers for more
  • 52:22for many of them as well as,
  • 52:25I think pretty good success in
  • 52:27measure in in measuring and designing
  • 52:29experiments for an underserved group.
  • 52:30Umm.
  • 52:31And I think that I'll briefly
  • 52:34just say that the research and
  • 52:37progress that I'm going.
  • 52:39Jump over really fast is kind of
  • 52:41an integrating different levels
  • 52:43of that analysis.
  • 52:46But I just want to thank this is
  • 52:48like some of the people in the ACT.
  • 52:51It's a lot. I mean they're all
  • 52:53everybody's really really really important
  • 52:54in it somehow only these really,
  • 52:56really really important people got on
  • 52:59this this slide and this is Jamie's lab
  • 53:01and this is a I don't know if this is
  • 53:04everybody's on here but it's a little
  • 53:06I think it's if you haven't you're
  • 53:08not on this list I apologize and then
  • 53:10I just acknowledge that participants
  • 53:12in the families and our support.
  • 53:13So thank you.
  • 53:25All right. Should I turn
  • 53:27off the chair? Good. Thank
  • 53:31you so much, Adam.
  • 53:32And I'm actually the distractor
  • 53:33in the middle of your talk
  • 53:34was from Linda Drozdowicz,
  • 53:35who was just complimenting you on
  • 53:37how accessible you were making EG.
  • 53:38So you're getting compliments
  • 53:40in the chat questions for Adam.
  • 53:50Adam, that was really great.
  • 53:51I really learned a lot from you today.
  • 53:53As always, I appreciate that.
  • 53:55Just a quick question about eye contact.
  • 53:57So I understand the difference of it
  • 53:59being predictable or not predictable
  • 54:00what the response is going to be,
  • 54:02but what about desirable or not desirable?
  • 54:05In some people they like eye contact, right?
  • 54:08But I have some patience and some
  • 54:10friends who really dislike eye contact.
  • 54:13And So what does that do to to make
  • 54:16your data even more complicated?
  • 54:19I'm, I was surprised at
  • 54:20how complicated it is.
  • 54:21But more complicated, you know, so,
  • 54:24but that desirability back there, you know,
  • 54:27some people like it and some don't.
  • 54:29Thank you.
  • 54:31Should I talk into this? Is that OK so.
  • 54:36I guess so on one level like.
  • 54:40Things like desirability might
  • 54:41be the kind of context I'm
  • 54:44talking about right today. They.
  • 54:49Those are the kinds of factors that
  • 54:52are probably, I think probably.
  • 54:54So I think they're probably.
  • 54:58Sort of charging up that piece
  • 55:00of brain where the end 170 is
  • 55:02being generated from really,
  • 55:03really early or not.
  • 55:05So I don't know that.
  • 55:10Like.
  • 55:13You know, the M70, it's this,
  • 55:15it's this peak that can be larger or smaller,
  • 55:18earlier or later. So it's not.
  • 55:20There's only so many places it can go.
  • 55:23So I. I guess like that's as I think
  • 55:26about this task, like the Stairmaster,
  • 55:29that might be like the tilt Table, right?
  • 55:32There might be other ways you can sort of.
  • 55:35Poken product. Thank you. Now
  • 55:39you're making me get my steps in,
  • 55:40so my heart rate is going to be going up.
  • 55:44I wonder about has there been any
  • 55:47experiment or data comparing,
  • 55:50I mean kids with autism in terms of
  • 55:52their eye tracking data when they
  • 55:54are or they are doing the experiment
  • 55:56on screen versus in the real life,
  • 55:59I mean as an in person experiment.
  • 56:02Yeah, we did one here years and years ago.
  • 56:08So. Here's the here's the big
  • 56:12caveat to all of those experiments.
  • 56:14So when I play you a movie on the screen,
  • 56:16it's the same movie.
  • 56:17Every kid who comes in sees the same movie.
  • 56:20When I put an eye tracker on your head,
  • 56:21it looks like just, you know,
  • 56:23now they can just look like glasses.
  • 56:25But if I put an eye tracker on
  • 56:27your head and I send you out?
  • 56:30I who knows where, where you're going to go?
  • 56:32So there's this.
  • 56:36It you you,
  • 56:37you can find that people might be less
  • 56:39prone to engage in social interactions
  • 56:41and then they look less at faces.
  • 56:43But probably what you want to know
  • 56:45is for those people who weren't
  • 56:47going to social interactions,
  • 56:49what would they have done if they were
  • 56:51in those socially charged situations
  • 56:52that the other people went into?
  • 56:55So it's sort of a.
  • 56:58Long way of also saying I don't
  • 57:02know and it's complicated.
  • 57:05Methadol just also just in
  • 57:07measurement and methodology,
  • 57:08measurement and methodology.
  • 57:10It's really hard to do that.
  • 57:13And get really accurate and
  • 57:15meaningful data for a single person.
  • 57:17When you have a 50 kids or 20 kids and
  • 57:19then you average it across all of them,
  • 57:21then you know, smooth it,
  • 57:22they smooth it again.
  • 57:24Then there's things come out of it.
  • 57:26But then at the individual level like this,
  • 57:30this issue of data loss,
  • 57:31again these are they start to creep in,
  • 57:33people make their own experiments and
  • 57:35usually they're not the experiments
  • 57:36that you wanted them to be in.
  • 57:41Mike.
  • 57:46Adam loved your talk,
  • 57:47great out of the park with all
  • 57:50the highly innovative approaches.
  • 57:52I've several questions. I'll
  • 57:54just ask the first one, which
  • 57:56is, have you thought about with
  • 57:57your your new shaping paradigm,
  • 58:01do you think that it changes the
  • 58:03brains of these kids in any way where
  • 58:05you might see that their
  • 58:06inhibitory controls improved?
  • 58:08Do you see any applications of
  • 58:09this beyond your experiment?
  • 58:14So. Yes, I don't think in the
  • 58:17sessions we're doing that.
  • 58:18There's like measurements of that we're
  • 58:20going to be measure like inhibitory
  • 58:22control changing because the amount
  • 58:24of change that happens within the
  • 58:26experiment is going to be driven by
  • 58:28how far away they were from sitting
  • 58:29still at the beginning, right.
  • 58:31So you're sort of.
  • 58:32It's like you're that baseline
  • 58:34is always going to be a predictor
  • 58:37of your outcome measure.
  • 58:39And but yeah, and I think it's,
  • 58:41I think it's a.
  • 58:42I do think it's a different
  • 58:45kind of experiment.
  • 58:46And I don't know there's like better or
  • 58:49worse than kind of the traditional ones,
  • 58:53but it's different.
  • 58:54And I don't know that we know
  • 58:57exactly every way in which those
  • 59:00differences might be important.
  • 59:02Sometimes,
  • 59:03and I've abandoned this,
  • 59:04we would say to participants,
  • 59:05try not to blink.
  • 59:06And you're layering your layering
  • 59:08on whatever your instructions are.
  • 59:10You know, someone is has those on
  • 59:11board while they're doing your task.
  • 59:12You really don't know how
  • 59:13much they're doing it.
  • 59:14So it's some ways similar
  • 59:15to what you're doing.
  • 59:16You're just doing it
  • 59:16implicitly. If, well,
  • 59:17I'll say it having been my own
  • 59:20participant hundreds of times,
  • 59:22it feels really different, right?
  • 59:24This is responding faster than your N 170 is.
  • 59:27So it feels, I mean it feels like,
  • 59:29you know, we've tied strings on to you
  • 59:32and they're hooked into the computer.
  • 59:33And that level of like.
  • 59:36That level of latency,
  • 59:39or lack of latency and perfect contingency.
  • 59:44It's it's you have it's
  • 59:46very implicit learning.
  • 59:47You don't think like oh I have to
  • 59:49sit still like you just sort of
  • 59:52it's a little bit for me I sort of
  • 59:55just freeze not freeze up that just
  • 59:57stopped moving and I don't think
  • 59:59about it explicitly so you think
  • 01:00:01do you feel it. The reason why I'm
  • 01:00:04asking is because we've done some
  • 01:00:06stuff with biofeedback and we'd relax
  • 01:00:09to keep a ball from when you relax,
  • 01:00:11a ball levitates. And with me,
  • 01:00:12every time it would levitate,
  • 01:00:13I get excited, then it would drop and so.
  • 01:00:16But I was thinking that, you know,
  • 01:00:19you could use this as a as an intervention in
  • 01:00:21some ways your approach.
  • 01:00:23Yeah, sounds like that.
  • 01:00:25Yeah, yeah, definitely have kids.
  • 01:00:27When, like, their favorite movie comes on,
  • 01:00:29they start getting excited.
  • 01:00:30And then you're like, OK, this is.
  • 01:00:32And you feel bad and it's like,
  • 01:00:33oh man, what have you done?
  • 01:00:38Wonderful. We're just about at time,
  • 01:00:40so we'll have a captive audience here.
  • 01:00:41I just like to remind you that we'll
  • 01:00:43be back here in the Cohen for grand
  • 01:00:44rounds next week for Doctor Lisa Gallia.
  • 01:00:46And previously at UBC,
  • 01:00:47now recently appointed by Camp H in Toronto,
  • 01:00:50we'll be talking about the impact
  • 01:00:52of biological sex on brain health.
  • 01:00:53So please join us for that.
  • 01:00:55But just to thank Doctor Naples for a
  • 01:00:57wonderfully accessible deep dive into
  • 01:00:59biomarkers in a really important area.
  • 01:01:01So thank you so much.
  • 01:01:03Thank you, guys.
  • 01:01:10Do I do something here?